Molecular genetic analysis of ependymal tumors: NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas

American Journal of Pathology

Volumn 155, Issue 2, 1999, Pages 627-632

  Ebert, Christian ^a   Von Haken, Markus ^a   Meyer Puttlitz, Birgit ^a   Wiestler, Otmar D ^a   Reifenberger, Guido ^a   Pietsch, Torsten ^a   Von Deimling, Andreas ^b,c  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CARCINOGENESIS; CHROMOSOME 10Q; CHROMOSOME 22Q; CHROMOSOME LOSS; CONTROLLED STUDY; EPENDYMOMA; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; INTRACRANIAL TUMOR; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SPINE TUMOR;

EID: 0032801037     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65158-9     Document Type: Article

References (43)

1. Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumours of the Central Nervous System. New York and Berlin, Springer-Verlag, 1993
2. Ross GW, Rubinstein LJ: Lack of hislopathological correlation of malignant ependymomas with postoperative survival. J Neurosurg 1989, 70:31-36
3. Lyons MK, Kelly PJ: Posterior fossa ependymomas: report of 30 cases and review of the literature, Neurosurgery 1991, 28:659-665 [discussion 664-665]
4. Robertson PL, Zeltzer PM, Boyett JM, Rorke LB, Allen JC, Geyer JR, Stanley P, Li H, Albright AL, McGuire-Cullen P, Finlay JL, Stevens KR, Jr., Milstein JM, Packer RJ, Wisoff J: Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. J Neurosurg 1998, 88:695-703
5. Sala F, Talacchi A, Mazza C, Prisco R, Ghimenton C, Bricolo A: Prognostic factors in childhood intracranial ependymomas: the role of age and tumor location. Pediatr Neurosurg 1998, 28:135-142
6. Mork SJ, Loken AC: Ependymoma: a follow-up study of 101 cases. Cancer 1977, 40:907-915
7. von Deimling A, von Ammon K, Schoenfeld D, Wiestler OD, Seizinger BR, Louis DN: Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 1993, 3:19-26
8. Maintz D, Fiedler K, Koopmann J, Rollbrocker B, Nechev S, Lenartz D, Stangl AP, Louis DN, Schramm J, Wiestler OD, von Deimling A: Molecular genetic evidence for subtypes of oligoastrocytomas. J Neuropathol Exp Neurol 1997, 56:1098-1104
9. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN: Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998, 90:1473-1479
10. Ohgaki H, Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW, Kleihues P: p53 mutations in nonastrocytic human brain tumors. Cancer Res 1991, 51:6202-6205
11. von Haken MS, White EC, Daneshvar-Shyesther L, Sih S, Choi E, Kalra R, Cogen PH: Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas. Genes Chromosom Cancer 1996, 17:37-44
12. Fink KL, Rushing EJ, Schold SC. Jr., Nisen PD: Infrequency of p53 gene mutations in ependymomas. J Neurooncol 1996, 27:111-115
13. Nozaki M, Tada M, Matsumoto R, Sawamura Y, Abe H, Iggo RD: Rare occurrence of inactivating p53 gene mutations in primary non-astrocytic tumors of the central nervous system: reappraisal by yeast functional assay. Acta Neuropathol (Berl) 1998, 95:291-296
14. Ransom DT, Ritland SR, Kimmel DW, Moertel CA, Dahl RJ, Scheithauer BW, Kelly PJ, Jenkins BR: Cytogenetic and loss of heterozygosity studies in ependymoma, pilocytic astrocytoma and oligodendrogliomas. Genes Chromosom Cancer 1992, 5:348-356
15. James CD, He J, Carlbom E, Mikkelsen T, Ridderheim P-A, Cavenee WK, Collins VP: Loss of genetic information in central nervous system tumors common to children and young adults. Genes Chromosom Cancer 1990, 2:94-102
16. Trofatter JA, MacCollin MM, Ruttner JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, Haase VH, Ambrose CM, Munroe D, Bove C, Haines JL, Martuza RL, MacDonald ME, Seizinger BR, Short MP, Buckler AJ, Gusella JF: A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993, 72:791-800
17. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Zuang K, Demczuk S, Desmaze C, Plougastel B, Pulst SM, Lenoir G, Bijlsma E, Fashold R, Dumanski J, de Jong P, Parry D, Eldridge R, Aurias A, Delattre O, Thomas G: Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 1993, 363:515-521
18. Martuza RL, Eldridge R: Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). N Engl J Med 1988, 318:684-688
19. Birch BD, Johnson JP, Parsa A, Desai RD, Yoon JT, Lycette CA, Li YM, Bruce JN: Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas. Neurosurgery 1996, 39:135-140
20. Rubio MP, Correa KM, Ramesh V, MacCollin MM, Jacoby LB, von Deimling A, Gusella JF, Louis DN: Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. Cancer Res 1994, 54:45-47
21. Slave I, MacCollin MM, Dunn M, Jones S, Sutton L, Gusella JF, Biegel JA: Exon scanning for mutations of the NF2 gene in pediatric ependymomas, rhabdoid tumors and meningiomas. Int J Cancer 1995, 64: 243-247
22. De Vitis LR, Tedde A, Vitelli F, Ammannati F, Mennonna P, Bono P, Grammatico B, Grammatico P, Radice P, Bigozzi U, Montali E, Papi L: Analysis of the neurofibromatosis type 2 gene in different human tumors of neuroectodermal origin. Hum Genet 1996, 97(5):638-641
23. Steck PA, Pershouse MA, Jasser SA, Yung WKA, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DHF, Tavtigian SV: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3that is mutated in multiple advanced cancers. Nature Genet 1997, 15:356-362
24. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997, 275:1943-1947
25. Duerr EM, Rollbrocker B, Hayashi Y, Peters N, Meyer-Puttlitz B, Louis DN, Schramm J, Wiestler OD, Parsons R, Eng C, von Deimling A: PTEN mutations in gliomas and glioneuronal tumors, Oncogene 1998, 16:2259-2264
26. Wang SI, Pue J, Li J, Bruce JN, Cairns P, Sidransky D, Parsons R: Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 1997, 57:4183-4186
27. Rasheed BK, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, Bigner DD, Bigner SH: PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res 1997, 57: 4187-4190
28. Boström J, Cobbers JMJ, Wolter M, Tabatabai G, Weber RG, Lichter P, Collins VP, Reifenberger G: Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Cancer Res 1998, 58:29-33
29. Bijlsma EK, Voesten AM, Bijleveld EH, Troost D, Westerveld A, Merel P, Thomas G, Hulsebos TJ: Molecular analysis of genetic changes in ependymomas. Genes Chromosom Cancer 1995, 13:272-277
30. Louis DN, von Deimling A, Seizinger BR: A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens. Am J Pathol 1992, 141:777-782
31. Jacoby LB, MacCollin M, Louis DN, Mohney T, Rubio MP, Pulaski K, Trofatter JA, Kley N, Seizinger B, Ramesh V, Gusella JF: Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 1994, 3:413-419
32. von Deimling A, Bender B, Louis DN, Wiestler OD: A rapid and non radioactive PCR based assay for the detection of allelic loss in human gliomas. Neuropathol Appl Neurobiol 1993, 19:524-529
33. Weremowicz S, Kupsky WJ, Morton CC, Fletcher JA: Cytogenetic evidence for a chromosome 22 tumor suppressor gene in ependymoma. Cancer Genet Cytogenet 1992, 61:193-196
34. Wernicke C, Thiel G, Lozanova T, Vogel S, Kintzel D, Janisch W, Lehmann K, Witkowski R: Involvement of chromosome 22 in ependymomas. Cancer Genet Cylogenet 1995, 79:173-176
35. Blaeker H, Rasheed BK, McLendon RE, Friedman HS, Batra SK, Fuchs HE, Bigner SH: Microsatellite analysis of childhood brain tumors. Genes Chromosom Cancer 1996, 15:54-63
36. Park JP, Chaffee S, Noli WW, Rhodes CH: Constitutional de novo t(1;22)(p22;q11.2) and ependymoma. Cancer Genet Cytogenet 1996, 86:150-152
37. Versteege I, Sevenel N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, Aurias A, Delattre O: Truncating mutations of hSNF5/ INI1 in aggressive paediatric cancer. Nature 1998, 394:203-206
38. Epstein FJ, Farmer JP, Freed D: Adult intramedullary spinal cord ependymomas: the result of surgery in 38 patients. J Neurosurg 1993, 79:204-209
39. McCormick PC, Torres R, Post KD, Stein BM: Intramedullary ependymoma of the spinal cord. J Neurosurg 1990, 72:523-532
40. Whitaker SJ, Bessell EM, Ashley SE, Bloom HJ, Bell BA, Brada M: Postoperative radiotherapy in the management of spinal cord ependymoma. J Neurosurg 1991, 74:720-728
41. Rawlings CEd, Giangaspero F, Burger PC, Bullard DE: Ependymomas: a clinicopathologic study. Surg Neurol 1988, 29:271-281
42. Mollenhauer J, Wiemann S, Scheurlen W, Korn B, Hayashi Y, Wilgenbus KK, von Deimling A, Poustka A: DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nature Genet 1997, 17:32-39
43. Somerville RP, Shoshan Y, Eng C, Barnett G, Miller D, Cowell JK: Molecular analysis of two putative tumour suppressor genes, PTEN and DMBT, which have been implicated in glioblastoma multiforme disease progression. Oncogene 1998, 17:1755-1757